Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Acta Medica Austriaca|January 1, 1991
[Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)]F Jung, P Waldhausen, S Spitzer, et al.International Angiology : a Journal of the International Union of Angiology|January 1, 1989
Control of therapy with microcirculatory and phlebotropically active drugs in patients with congenital and acquired venous insufficiencyE Wenzel, L Birkel, P Scheffler, et al.Infusionstherapie Und Klinische Ernahrung|October 1, 1987
[Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands]P Scheffler, F Jung, C Mrowietz, et al.Infusionstherapie (Basel, Switzerland)|December 1, 1988
[Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)]F Jung, P Waldhausen, S Spitzer, et al.Infusionstherapie (Basel, Switzerland)|August 1, 1989
[Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)]F Jung, P Waldhausen, C Mrowietz, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 4, 2004
Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemiaS Schellong, E Altmann, P von Bilderling, et al.Wiener Medizinische Wochenschrift (1946)|September 15, 1989
[Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease]H Kiesewetter, J Blume, F Jung, et al.Acta Medica Austriaca|January 1, 1991
[Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage]P Waldhausen, H Kiesewetter, G Leipnitz, et al.VASA. Zeitschrift Fur Gefasskrankheiten|July 23, 2011
Trends in amputations in people with hospital admissions for peripheral arterial disease in GermanyT Moysidis, T Nowack, F Eickmeyer, et al.Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters]M Köhler, S Mörsdorf, F Jung, et al.Pageof 2